Sunshine Lake Pharma Co., Ltd.

North & South Brother Pharmacy Investment Company Limited

Pengcho Tang

Zheng Gu

Panpan Kang

Zongyuan Zhang

Wuyong Wu

Gang Chen

Yonggang Wei

Yincai Wang

Mingyun Yuan

Jiaping Wen

Guozhi Zhu

Yonghua Lu

Heran Wang

Zhe Zhu

Tong Qu

Yang Chen

Xiangqin Li

Kangzhi Ye

Guizhuan Su

Guanpeng Qiu

Chengsheng Lan

Bin Wang

Xin Li

This present invention relates to a complex of a glucopyranosyl derivative and L-pyroglutamic acid as a sodium dependent glucose cotransporter (SGLT) inhibitor, and preparation processes thereof, and a pharmaceutical composition containing the complex, and their uses in the manufacture of a medicament for treating diabetes and/or diabetes-related diseases.

Complex of a glucopyranosyl derivative and preparation method and use thereof

The invention relates to hexahydropentaleno derivatives, the preparation method and use in medicine thereof, and in particular to hexahydropentaleno derivatives or stereo-isomers or pharmaceutically acceptable salts thereof as shown in general formula (I), and to the preparation method therefor and pharmaceutical compositions comprising the derivatives, and to the use thereof as a therapeutical agent, especially as a DPP-IV inhibitor. The definition of each substituent in formula (I) is the same as the definition in the description. 

Hexahydropentaleno derivatives, preparation method and use in medicine thereof

Disclosed are glucopyranosyl derivatives used as sodium dependent glucose cotransporters (SGLTs) inhibitors, intermediates or preparation processes thereof, and pharmaceutical uses thereof, especially glucopyranosyl derivatives represented by Formula (I), or pharmaceutically acceptable salts or all stereoisomers thereof, pharmaceutical compositions containing these derivatives and their uses for treatment of diabetes and diabetes-related diseases. 

Glucopyranosyl derivatives and their uses in medicine

Growing community of inventors

Dongguan, China

Pengcho Tang